6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The optimal timing and duration of immunosuppressive therapy for idiopathic membranous nephropathy (iMN) have been debated. This study aimed to evaluate whether measuring the antibody against the phospholipase A2 receptor (PLA2R-ab) at start and end of therapy predicts long-term outcome and therefore may inform this debate.

          Related collections

          Author and article information

          Journal
          Clin J Am Soc Nephrol
          Clinical journal of the American Society of Nephrology : CJASN
          1555-905X
          1555-9041
          Aug 7 2014
          : 9
          : 8
          Affiliations
          [1 ] Department of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands; and Anneke.vanderWoude-Bech@radboudumc.nl.
          [2 ] Department of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands; and.
          [3 ] Manchester Institute of Nephrology and Transplantation, Manchester, United Kingdom.
          Article
          CJN.10471013
          10.2215/CJN.10471013
          25035272
          4615ed67-35ea-4b37-a499-790538130ea9
          Copyright © 2014 by the American Society of Nephrology.
          History

          anti-PLA2R antibodies,disease course,immunosuppressive,membranous nephropathy,therapy

          Comments

          Comment on this article